1Assistant Professor, Tuberculosis and Respiratory Diseases, SHKMGMC
2Senior resident Deptt., Dentistry, SHKMGMC
3Professor Deptt., Pediatrics, SHKMGMC
4Associate Professor, Community Medicine, SHKMGMC
5Assistant Professor Deptt., of Medicine, SHKMGMC
6Professor Deptt., of Forensic Medicine, SHKMGMC
*Corresponding Author E-mail: dr.parveenranga@gmail.com
Online Published on 10 October, 2023.
We assess the profile of adverse events following immunization of COVID - 19 vaccination of COVISHIELD in health care workers (HCWs) in Shaheed Hasan Khan Mewati Govt. Medical college Nalhar, Nuh, Haryana, India.
The Cross sectional and prospective observational study was conducted with a period of 3 months or till the desired sample size recruited in the study with follow up period of 15 days for all those subjects who were vaccinated for covid-19 in SHKM, GMC Hospital to look for AEFI with sample size more than 300. Active surveillance was done on days 3, 6 and 9 after days of vaccination for AEFI). Any AEFI noted will be managed as per the standard guidelines.
We present the results of an interim analysis of 400 patients out of total 550 participants with 244(61.00%) male and 156 (39.00%) female participants respectively. AEFIs following first dose were reported in 400 participants and 269 participants after second dose. Fever was the major AEFI with 150(37.50%) after first dose and 78(28.99%) after second dose respectively. In the study age wise AEFIs percentage of participants were also calculated. In the present study different systemic diseases percentage also calculated.
The AEFIs associated with the COVISHIELD (ChAdOx1 nCoV-19), the COVID-19 vaccine injected in hospital health care workers is found to be safe for use in except for a few minor reactions.
COVISHIELD, COVID-19, Vaccination, Adverse Events Following Immunization, AEFI
